Alteration of sulfate and hydrogen metabolism in the human colon by changing intestinal transit rate

American Journal of Gastroenterology

Volumn 102, Issue 3, 2007, Pages 624-633

  Lewis, Stephen ^a   Cochrane, Séan ^a  

^a DERRIFORD HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; BILE ACID; HYDROGEN; LOPERAMIDE; METHANE; METHIONINE; PLACEBO; SHORT CHAIN FATTY ACID; SULFATE; SULFIDE;

ADULT; ARTICLE; DIETARY INTAKE; FECES ANALYSIS; FECES MICROFLORA; HUMAN; HUMAN EXPERIMENT; INTESTINE MOTILITY; METABOLISM; METHANOGEN; METHANOGENIC BACTERIUM; NORMAL HUMAN; PRIORITY JOURNAL; SENNA; TIME; URINALYSIS; URINARY EXCRETION;

ACETIC ACID; ADULT; BIOLOGICAL MARKERS; COLON; DIETARY SUPPLEMENTS; FATTY ACIDS, VOLATILE; FECES; FOLLOW-UP STUDIES; GASTROINTESTINAL TRANSIT; HUMANS; HYDROGEN; HYDROGEN SULFIDE; METHIONINE; PROGNOSIS; REFERENCE VALUES; SULFATES;

EID: 33847294713     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.01020.x     Document Type: Article

References (70)

1. Chapman RW, Sillery JK, Graham MM, et al. Absorption of starch by healthy ileostomates: Effect of transit time and carbohydrate load. Am J Clin Nutr 1985;41:1244-8.
2. Holgate AM, Read NW. Relationship between small bowel transit time and absorption of a solid meal. Dig Dis Sci 1983;28:812-9.
3. Lewis SJ, Heaton KW. Increasing butyrate concentration in the distal colon by accelerating intestinal transit. Gut 1997;41:245-51.
4. El Oufir E, Flourié B, Varannes SB, et al. Relations between transit time, fermentation products, and hydrogen consuming flora in healthy humans. Gut 1996;38:870-7.
5. Lewis SJ, Oakey RE, McGariggle HHG, et al. Reduction in serum oestrogens associated with increased intestinal transit rate. Br J Cancer 1997;76:395-400.
6. Marcus SN, Heaton KW. Intestinal transit, deoxycholic acid and the cholesterol saturation of bile: Three inter-related factors. Gut 1986;27:550-8.
7. Stephen AM, Wiggins HS, Cummings JH. Effect of changing transit time on colonic microbial metabolism in man. Gut 1987;28:601-9.
8. Cummings JH. Diet and transit through the gut. J Plant Foods 1978;3:83-95.
9. Burkitt DP, Walker ARP, Painter NS. Effect of dietary fibre on stools and transit times and its role in the causation of disease. Lancet 1972;ii:1408-12.
10. Burkitt DP. Epidemiology of cancer of the colon and rectum. Cancer 1971;28:3-13.
11. Cummings JH, Bingham SA, Heaton KW, et al. Fecal weight, colon cancer risk, and dietary intake of nonstarch polysaccharides (dietary fibre). Gastroenterology 1992;103:1783-9.
12. Christl SU, Murgatroyd PR, Gibson GR, et al. Production, metabolism and excretion of hydrogen in the large intestine. Gastroenterology 1992;102:1269-77.
13. Smith L, Kryszyna H, Smith RP. The effect of methaemoglobin on the inhibition of cytochrome C oxidase by cyanide, sulfide or azide. Biochem Pharmacol 1977;22:47-50.
14. Florin THJ, Neale G, Cummings JH. The effect of hydrogen sulphide on isolated colonic epithelium. In: Advances in the Treatment of Ulcerative Colitis, Falk Symposium, Freibury, Germany, 1990.
15. Roediger WEW, Duncan A, Kapaniris O, et al. Reducing sulfur compounds of the colon impair colonocyte nutrition: Implications for ulcerative colitis. Gastroenterology 1993;104:802-9.
16. Roediger WEW, Duncan A, Kapaniris O, et al. Sulphide impairment of substrate oxidation in rat colonocytes: A biochemical basis for ulcerative colitis? Clin Sci 1993;85:623-7.
17. Pitcher MCL, Cummings JH. Hydrogen sulphide: A bacterial toxin in ulcerative colitis. Gut 1996;39:1-4.
18. Roediger WEW, Moore J, Babidge W. Colonic sulfide in pathogenesis and treatment of ulcerative colitis. Dig Dis Sci 1997;42:1571-9.
19. Segal I, Walker ARP, Lord S, et al. Breath methane and large bowel cancer risk in contrasting African populations. Gut 1988;29:608-13.
20. Florin THJ, Neale G, Gibson GR, et al. Metabolism of dietary sulphate: Absorption and excretion in humans. Gut 1991;32:766-73.
21. Florin THJ, Neale G, Goretski S, et al. The sulfate content of foods and beverages. J Food Comp Anal 1993;6:140-51.
22. Paul AA, Southgate DAT. McCance and Widdowson's, The composition of foods. Amsterdam, New York, and Oxford: Elsevier/North-Holland Biomedical Press, 1978.
23. Englyst HN, Bingham SA, Runswick SA, et al. Dietary fibre (non-starch polysaccharides) in cereal products. J Hum Nutr Diet 1989;2:253-71.
24. Englyst HN, Bingham SA, Runswick SA, et al. Dietary fibre (non-starch polysaccharides) in fruit, vegetables and nuts. J Hum Nutr Diet 1988;1:247-86.
25. Read NW, Miles CA, Fisher D, et al. Transit of a meal through the stomach, small intestine, and colon in normal subjects and its role in the pathogenesis of diarrhoea. Gastroenterology 1980;79:1276-82.
26. Probert CSJ, Emmett PM, Heaton KW. Intestinal transit time in the population calculated from self made observations of defecation. J Epidemiol Comm Health 1993;47:331-3.
27. O'Donnell LJD, Virjee J, Heaton KW. Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate. BMJ 1990;300:439-40.
28. Beerens H. An elective and selective isolation medium for Bifidobacterium spp. Lett Appl Microbiol 1990;11:155-7.
29. Postgate JR. The sulphate-reducing bacteria. Cambridge: Cambridge University Press, 1984.
30. Miller TL, Wolin MJ. A serum bottle modification of the Hungate technique for cultivating obligate anaerobes. Appl Microbiol 1974;27:985-7.
31. Cline JD. Spectrophotometric determination of hydrogen sulfide in natural water. Limnol Oceanogr 1969;14:454-8.
32. Rowan AM, Moughan PJ, Wilson MN, et al. Comparison of ileal and fecal digestibility of dietary amino acids in adult humans and evaluation of the pig as a model animal for digestion studies in man. Br J Nutr 1994;71:29-42.
33. MacFarlane GT, Gibson GR. Sulphate reducing bacteria. In: PN L, ed. Anaerobic microbiology - a practical approach. Oxford: Oxford University Press, 1991:201-22.
34. Spiller GA, Chernoff MC, Hill RA, et al. Effect of purified cellulose, pectin, and a low-residue diet on fecal volatile fatty acids, transit time, and fecal weight in humans. Am J Clin Nutr 1980;33:754-9.
35. Lajoie SF, Bank S, Miller TL, et al. Acetate production from hydrogen and [†3C]carbon dioxide by the microflora of human feces. Appl Environ Microbiol 1988;54:2723-7.
36. 2-utilizing acetogenic bacteria from feces of nonmethane-producing humans. Curr Microbiol 1996;33:94-9.
37. Allison C, Macfarlane GT. Effect of nitrate upon methane production by slurries of human fecal bacteria. J Gen Microbiol 1988;134:1397-405.
38. Van Faassen A, Nagengast FM, Hectors M, et al. Determination of individual human fecal bile acids by gas-liquid chromatography after enzymatic deconjugation and simultaneous solvolysis and methylation using dimethoxypropane. Clin Chim Acta 1985;152:231-9.
39. Pochart P, Doré J, Lémann F, et al. Interrelations between populations of methanogenic archaea and sulfate-reducing bacteria in the human colon. FEMS Microbiol Lett 1992;98:225-8.
40. Weaver GA, Krause JA, Miller TL, et al. Incidence of methanogenic bacteria in sigmoidoscopy population: An association of methanogenic bacteria and diverticulosis. Gut 1986;27:698-704.
41. Magee EAM, Curno R, Edmond LM, et al. Contribution of dietary protein and inorganic sulfur to urinary sulfate: Towards a biomarker of inorganic sulfur intake. Am J Clin Nutr 2004;80:137-42.
42. Gibson JA, Sladen GE, Dawson AM. Protein absorption and ammonia production: The effects of dietary protein and removal of the colon. Br J Nutr 1976;35:61-5.
43. Magee EAM, Richardson CJ, Hughes R, et al. Contribution of dietary protein to sulfide production in the large intestine: An in vitro and a controlled feeding study in humans. Am J Clin Nutr 2000;72:1488-94.
44. Fiorucci S, Distrutti E, Cirino G, et al. The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver. Gastroenterology 1006;131:259-71.
45. Søgaard H. Hydrogen sulphide producing variants of Escherichia coli. Acta Vet Scand 1975;16:31-8.
46. MacFarlane GT, Gibson GR, Cummings JH. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 1992;72:57-64.
47. Gibson GR, Macfarlane S, Macfarlane GT. Metabolic interactions involving sulphate-reducing and methanogenic bacteria in the human large intestine. FEMS Microbiol Ecol 1993;12:117-25.
48. Pitcher MCL, Beatty ER, Cummings JH. The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to fecal sulphide in patients with ulcerative colitis. Gut 2000;46:64-72.
49. Rao SSC, Read NW, Brown C, et al. Studies on the mechanism of bowel disturbance in ulcerative colitis. Gastroenterology 1987;93:934-40.
50. Schmedes A, Nielsen JN, Hey H, et al. Low S-adenosylmethionine concentrations found in patients with severe inflammatory bowel disease. Clin Chem Lab Med 2004;42:648-53.
51. Ramasamy S, Singh S, Taniere P, et al. Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation. Am J Gastrointest Liver Physiol 2006;291:G288-96.
52. Kitano A, Kobayashi K, Oshiumi H, et al. Studies of experimental ulcerative colitis induced by carrageenan in rabbits. Jpn J Gastroenterol 1981;78:2104-11.
53. Van De Waaji D, Cohen BJ, Anver MR. Mitigation of experimental inflammatory bowel disease in guinea pigs by selective elimination of the aerobic gram-negative intestinal microflora. Gastroenterology 1974;67:460-72.
54. Onderdonk AB, Hermos JA, Dzink JL, et al. Protective effect of metronidazole in experimental ulcerative colitis. Gastroenterology 1978;74:521-6.
55. Lewis S, Brazier J, Beard D, et al. Effects of oligofructose and metronidazole on fecal concentrations of sulphate reducing bacteria, short chain fatty acids and sulphide. Scand J Gastroenterol 2005;40:1296-303.
56. Chapman RW, Selby WS, Jewel DP. Controlled trial of metronidazole as an adjunct to corticosteroids in severe ulcerative colitis. Gut 1986;27:1210-2.
57. Mantzaris GJ, Hatzis A, Kontogiannis P, et al. Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. Am J Gastroenterol 1994;89:43-6.
58. Mantzaris GJ, Archavlis E, Christoforidis P, et al. A prospective randomized controlled trial of oral ciprofloxacin in acute ulcerative colitis. Am J Gastroenterol 1997;92:454-6.
59. Roediger WEW. Decreased sulpher aminoacid intake in ulcerative colitis. Lancet 1998;351:1555.
60. Jowett SL, Seal CJ, Pearce MS, et al. Influences of dietary factors on the clinical course of ulcerative colitis: A prospective cohort study. Gut 2004;53:1479-84.
61. Florin THJ, Woods HJ. Inhibition of methanogenesis by human bile. Gut 1995;37:418-21.
62. Christl SU, Gibson GR, Cummings JH. Role of dietary sulphate in the regulation of methanogenesis in the human large intestine. Gut 1992;33:1234-8.
63. Yadav VK, Archer DB. Specific inhibition of sulphate-reducing bacteria in methanogenic co-culture. Lett App Microbiol 1988;7:165-8.
64. Gibson GR, MacFarlane GT, Cummings JH. Sulphate reducing bacteria and hydrogen metabolism in the human large intestine. Gut 1993;34:437-9.
65. Levine J, Ellis CJ, Furne JK, et al. Fecal hydrogen sulfide production in ulcerative colitis. Am J Gastroenterol 1998;93:83-7.
66. Gibson GR, Cummings JH, Macfarlane GT, et al. Alternative pathways for hydrogen disposal during fermentation in the human colon. Gut 1990;31:679-83.
67. Wolin MJ, Miller TL, Yerry S, et al. Changes in fermentation pathways of fecal microbial communities associated with a drug treatment that increases dietary starch in the human colon. Appl Environ Microbiol 1999;65:2807-12.
68. McBurney MI, Thompson LU. Effect of human fecal donor on in vitro fermentation variables. Scand J Gastroenterol 1989;24:359-67.
69. Ikeda N, Saito Y, Shimizu J, et al. Variations in concentrations of bacterial metabolites, enzyme activities, moisture, pH and bacterial composition between and within individuals in faeces of seven healthy adults. J Appl Bacteriol 1994;77:185-94.
70. Zinkevich V, Beech IB. Screening of sulphate reducing bacteria in colonoscopy samples from healthy and colitic human gut mucosa. FEMS Microb Ecol 2000;34:147-55.